1.
The Analysis of National Drug Policy and the Application of Pharmacoeconomics Evaluation in Chinese Drug Policy;
药物政策分析及药物经济学在我国药物政策中的应用研究
2.
How to formulate and implement national medicines policy:experiences and lessons learnt from India for China
制定并落实目标全面的国家药物政策:印度经验与教训
3.
Dual Shortages:An Institutional Analysis of Essential Drug Policy-On the New Health Care Plan in China
双向短缺:基本药物政策的制度分析——兼评“新医改”方案的缺陷
4.
International Drug Control Strategy and Policies
国际药物管制战略和政策
5.
programme of international drug abuse control strategy and policies
国际药物滥用管制战略和政策方案
6.
Policy Proposals for Improvement of Essential Medicine System in China
完善我国基本药物制度若干政策建议
7.
An Analysis of the Public Policy of the Federal Government of USA on the Regulation of Food and Drug;
美国联邦政府食品药物管制的公共政策分析
8.
Policies and Laws Concerning Protection of Nonmaterial Cultural Heritage of Chinese Medicine;
中医药非物质文化遗产保护的政策法律措施
9.
Government s Obligation of Nominal High Price of Drug and Countermeasures;
药物价格虚高现状的政府责任及对策研究
10.
International Trade Policy Selection of Chinese Biological Pharmaceutical Industry;
我国生物医药产业国际贸易的政策选择
11.
Study on the supply guarantee system of essential medicine under the new medical reform policy frame
新医改政策框架下基本药物供应保障体系探究
12.
The comparative study on supervision and incentive policies of Sino-US during the innovative drug R&D
中美创新药物研发监管激励政策的比较研究
13.
Analysis and policy implications of the issues on production of essential medicine
基本药物生产存在问题分析和政策建议
14.
Economic Analysis on the Shortage of Low-price Essential Medicines Caused by Price-lowering Policy;
药品降价政策之弊:廉价基本药物短缺的经济学分析
15.
Public Policies of Government on the Growth of Biopharmaceutical Companies in Kunming Study on the Factors Affecting
政府公共政策对生物制药企业成长的影响因素研究
16.
Carrying Out Pharmacoeconomic Study in China:Necessity,Problems and Suggestions
在我国开展药物经济学研究的必要性、存在问题及政策建议
17.
Introduction of WHO's Biowaiver Policy for Oral Generic Drugs
WHO关于口服仿制药生物等效豁免相关政策的介绍
18.
Strategy of molecular drug design: dual-target drug design
药物分子设计的策略:双靶标药物设计